Article Per Year (5 Year)
p-Index From 2021 - 2026
0.444
P-Index
This Author published in this journals
All Journal Jurnal Health Sains
Teddy Tjahyanto
Universitas Tarumanagara (UNTAR) Jakarta, Indonesia
Dentistry Health Professions Medicine & Pharmacology Nursing Public Health Veterinary

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Hubungan Kecerdasan Emosional terhadap Tingkat Depresi Mahasiswa Fakultas Kedokteran Universitas Tarumanagara Teddy Tjahyanto; Ni Kanaya; Grace Keren; Eunike Angellina Mulyadi; Kevin Sanjaya Listiono
Jurnal Health Sains Vol. 2 No. 8 (2021): Jurnal Health Sains
Publisher : Syntax Corporation Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.46799/jhs.v2i8.259

Abstract

The World Health Organization (WHO) recognize the COVID-19 pandemic as an imminent global threat. To dampen the spread of the highly-contagious virus, the Indonesian government has imposed several social-distancing and government regulations. Nonetheless, these regulations result in peripheral effects; many people are subject to loneliness, fear, and anxiety—all of which leads to depression. Statistical evidence show that depression is very much prevalent in Indonesians—reaching a staggering 62% as of August 2020. Multiple studies have proven the negative correlation between emotional intelligence—which is the ability to regulate and control emotions—and depression. Consequently, this study aims to determine the relationship between emotional intelligence and depression in medical students of Universitas Tarumanagara batch 2019. Using a descriptive analytic research design with a cross-sectional approach, we obtained data through simple random sampling a total of 154 respondents who answered an emotional intelligence questionnaire used as a proxy in determining the level of emotional intelligence. Statistical analysis using the chi-square test confirmed that there is a significant negative correlation between emotional intelligence and depression during the COVID-19 pandemic, yielding a p-value of 0.003. In conclusion, students can improve their level of emotional intelligence as a preventive measure of depression during the COVID-19 pandemic.
Aktivitas Antivirus Polifenol sebagai Profilaksis dan Terapi Potensial dalam Penanganan Covid-19 Teddy Tjahyanto; Eldy Eldy; Clarissa Felicia; Karmenia Jessica Karmenia Jessica; Olivia Larissa
Jurnal Health Sains Vol. 3 No. 2 (2022): Jurnal Health Sains
Publisher : Syntax Corporation Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.46799/jhs.v3i2.428

Abstract

COVID-19 has caused serious health problems worldwide. Until now, the available therapy hasn’t been fully effective in improving outcomes in COVID-19 patients. Due to the long process of discovering new drugs, the use of available treatment becomes a solution.  However, this therapy has several drawbacks, such as decreased effectiveness in mutated viruses and various serious side effects that accompany it. Polyphenols can be considered as adjunctive therapy for COVID-19 because of their rich variety and antiviral activities. This literature review was conducted to summarize the latest evidence regarding the potential antiviral activity of polyphenols as both prophylactic and therapeutic for COVID-19, as well as further discussion on encouragement of polyphenol intake from diets and recommended food examples. Literature sources were taken from journal articles published online from 2017 to 2021. The databases used were MDPI, PubMed, ScienceDirect, Wiley, and Hindawi. Research shows the use of polyphenolic compounds has been approved as a beneficial nutritional or adjunctive therapeutic approach for COVID-19. This is based on the role of polyphenol bioactivity in the pathophysiology of COVID-19, including antioxidant, antiviral, anti-inflammatory, and immunomodulatory effects. Additional studies that specifically examine the administration of polyphenols to pregnant COVID-19 patients and dose safety limits related to interactions with drugs used in the treatment of COVID-19 need to be conducted.
Co-Authors Clarissa Felicia Eldy Eldy Eunike Angellina Mulyadi Grace Keren Karmenia Jessica Karmenia Jessica Kevin Sanjaya Listiono Ni Kanaya Olivia Larissa